Skip to content

Palisade Bio, Inc.

PALI· NasdaqCore metricsCIK 1357459

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -1.71%
Market cap
$206.17M
179.28M shares
Filings
1,026
$0.00
Q3 2026
-$14.62M
Q3 2026N/M FY25 yoy
-$15.70M
Q3 2026N/M FY25 yoy
-$12.19M
FY 2024derivedN/M FY24 yoy
-$0.07
Q3 2026N/M FY25 yoy
$113.61M
Q3 2026+1,258.2% FY25 yoy
$206.17M
—
412.3×
1.8×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$1.1536.81%$0.67past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$260.00K0FY 2013FY 2018FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$250,000reported
FY 20222022-12-31$0reported
FY 20202020-12-31$13,520reported
FY 20192019-12-31$15,394reported
FY 20182018-12-31$260,000reported
FY 20172017-12-31$260,000reported
FY 20162016-12-31$16,246reported
FY 20152015-12-31$10,417reported
FY 20142014-12-31$18,833reported
FY 20132013-12-31$110,000reported

Biological products, except diagnostic substances

Palisade Bio, Inc. is the 89th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR